A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review [version 2; referees: 2 approved]
Background: Stigma, poverty, and lack of knowledge present barriers to the diagnosis and treatment of chronic infection, especially in resource-limited settings. Chronic Hepatitis B virus (HBV) infection is frequently asymptomatic, but accounts for a substantial long-term burden of morbidity and mor...
Main Authors: | Jolynne Mokaya, Anna L McNaughton, Lela Burbridge, Tongai Maponga, Geraldine O'Hara, Monique Andersson, Janet Seeley, Philippa C Matthews |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2018-08-01
|
Series: | Wellcome Open Research |
Online Access: | https://wellcomeopenresearch.org/articles/3-29/v2 |
Similar Items
-
A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
by: Mokaya, J, et al.
Published: (2018) -
A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.
by: Jolynne Mokaya, et al.
Published: (2018-08-01) -
Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms [version 1; peer review: 2 approved]
by: Jolynne Mokaya, et al.
Published: (2020-06-01) -
Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
by: Anna L McNaughton, et al.
Published: (2020-04-01) -
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
by: Jolynne Mokaya, et al.
Published: (2019-06-01)